An induced pluripotent stem cell t(7;12)(q36;p13) acute myeloid leukemia model shows high expression of MNX1 and a block in differentiation of the erythroid and megakaryocytic lineages

Int J Cancer. 2022 Sep 1;151(5):770-782. doi: 10.1002/ijc.34122. Epub 2022 Jun 3.


Acute myeloid leukemia (AML) results from aberrant hematopoietic processes and these changes are frequently initiated by chromosomal translocations. One particular subtype, AML with translocation t(7;12)(q36;p13), is found in children diagnosed before 2 years of age. The mechanisms for leukemogenesis induced by t(7;12) is not understood, in part because of the lack of efficient methods to reconstruct the leukemia-associated genetic aberration with correct genomic architecture and regulatory elements. We therefore created induced pluripotent stem cell (iPSC) lines that carry the translocation t(7;12) using CRISPR/Cas9. These t(7;12) iPSC showed propensity to differentiate into all three germ layers, confirming retained stem cell properties. The potential for differentiation into hematopoietic stem and progenitor cells (HSPC) was shown by expression of CD34, CD43 and CD45. Compared with the parental iPSC line, a significant decrease in cells expressing CD235a and CD41a was seen in the t(7;12) iPSC-derived HSPC (iHSPC), suggesting a block in differentiation. Moreover, colony formation assay showed an accumulation of cells at the erythroid and myeloid progenitor stages. Gene expression analysis revealed significant down-regulation of genes associated with megakaryocyte differentiation and up-regulation of genes associated with myeloid pathways but also genes typically seen in AML cases with t(7;12). Thus, this iPSC t(7;12) leukemia model of the t(7;12) AML subtype constitutes a valuable tool for further studies of the mechanisms for leukemia development and to find new treatment options.

Keywords: AML; chromosome translocation; leukemia; pluripotency; stem cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation* / genetics
  • Child
  • Gene Expression / genetics
  • Gene Expression / physiology
  • Gene Expression Profiling
  • Hematopoietic Stem Cells / physiology
  • Homeodomain Proteins* / genetics
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Leukemia, Myeloid, Acute* / genetics
  • Megakaryocyte-Erythroid Progenitor Cells* / physiology
  • Megakaryocytes / physiology
  • Transcription Factors* / genetics
  • Translocation, Genetic


  • Homeodomain Proteins
  • MNX1 protein, human
  • Transcription Factors